Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYAD

Celyad (CYAD) Stock Price, News & Analysis

Celyad logo

About Celyad Stock (NASDAQ:CYAD)

Advanced Chart

Key Stats

Today's Range
$0.40
$0.65
50-Day Range
$0.59
$0.85
52-Week Range
$0.46
$3.07
Volume
3,009 shs
Average Volume
N/A
Market Capitalization
$15.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celyad and its competitors with MarketBeat's FREE daily newsletter.

CYAD Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Celyad Oncology Announces Strategic Review
Celyad Oncology to Present at the 2024 SITC Annual Meeting
See More Headlines

CYAD Stock Analysis - Frequently Asked Questions

Celyad (CYAD) raised $99 million in an initial public offering (IPO) on Friday, June 19th 2015. The company issued 1,400,000 shares at a price of $70.98 per share. UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Petercam Bryan, Garnier, LifeSci Capital and Lake Street Capital Markets were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Celyad investors own include Galapagos (GLPG), Cellectis (CLLS), CRISPR Therapeutics (CRSP), Gilead Sciences (GILD), bluebird bio (BLUE), Bristol Myers Squibb (BMY) and ChromaDex (CDXC).

Company Calendar

Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED-BIOMED/GENE
Sub-Industry
N/A
Current Symbol
NASDAQ:CYAD
CIK
1637890
Employees
95
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
1.49
Current Ratio
2.29
Quick Ratio
2.14

Sales & Book Value

Annual Sales
$200 thousand
Price / Sales
79.56
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.02 per share
Price / Book
30.00

Miscellaneous

Outstanding Shares
26,520,000
Free Float
26,276,000
Market Cap
$15.91 million
Optionable
Not Optionable
Beta
N/A

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:CYAD) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners